TrialThe Journal of clinical endocrinology and metabolism2026

Cardiac safety of chronic inhibition of the myostatin-activin pathway with bimagrumab in healthy older adults.

Daniel Rooks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.